◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
恒瑞医药 — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
+Revenue 28.0B 22.8B 21.3B 25.9B 27.7B
Revenue Growth % 22.6% 7.3% -17.9% -6.6% --
Total Revenue 28.0B 22.8B 21.3B 25.9B 27.7B
Cost Of Revenue 3.8B 3.5B 3.5B 3.7B 3.3B
+Gross Profit 24.1B 19.3B 17.8B 22.2B 24.4B
Gross Margin % 86.2% 84.6% 83.6% 85.6% 87.9%
Total Operating Cost 21.0B 18.3B 17.9B 21.8B 21.3B
Selling Expenses 8.3B 7.6B 7.3B 9.4B 9.8B
Admin Expenses 2.6B 2.4B 2.3B 2.9B 3.1B
Rd Expenses 6.6B 5.0B 4.9B 5.9B 5.0B
Finance Expenses -573.0M -478.0M -471.0M -338.0M -182.0M
+Operating Income 7.5B 4.9B 4.1B 4.7B 7.0B
Operating Margin % 26.8% 21.5% 19.3% 18.0% 25.3%
Non Operating Income 10.4M 3.8M 2.1M 2.2M 1.1M
Non Operating Expenses 331.0M 247.0M 146.0M 201.0M 113.0M
Investment Income 4.3M -49.2M 387.0M 213.0M 341.0M
Fair Value Change Income 109.0M -58.3M 76.5M 36.2M 16.5M
Asset Disposal Income 5.4M 3.2M 5.5M 3.4M 3.0M
Asset Impairment Loss 32.5M 107.0M 147.0M 13.9M 7.3M
Other Income 399.0M 498.0M 287.0M 309.0M 208.0M
Income Before Tax 7.2B 4.7B 4.0B 4.5B 6.9B
Income Tax 833.0M 389.0M 153.0M -17.7M 587.0M
+Net Income 6.3B 4.3B 3.8B 4.5B 6.3B
Net Margin % 22.6% 18.7% 17.9% 17.3% 22.7%
Net Income Attributable 6.3B 4.3B 3.9B 4.5B 6.3B
Minority Interest 467,600 -24.6M -91.2M -46.2M -19.5M
Eps Basic 1.00 0.68 0.61 0.71 0.99
Eps Diluted 1.00 0.68 0.61 0.71 0.99
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
Cash And Equivalents 24.8B 20.7B 15.1B 13.6B 10.8B
Trading Financial Assets 273.0M 99.0M 2.8B 5.1B 5.6B
Accounts Receivable 4.9B 5.2B 5.9B 4.6B 5.1B
Notes Receivable 150.0M 326.0M 503.0M 1.1B --
Notes And Accounts Receivable 5.1B 5.5B 6.4B 5.7B 5.1B
Prepayments 1.1B 1.2B 1.1B 973.0M 562.0M
Inventory 2.4B 2.3B 2.5B 2.4B 1.8B
Total Current Assets 35.3B 31.3B 30.9B 30.2B 28.1B
Long Term Equity Investment 666.0M 695.0M 768.0M 193.0M 60.0M
Fixed Assets -- 5.5B 5.4B 4.5B 3.3B
Fixed Assets Total 5.1B 5.5B 5.4B 4.5B 3.3B
Construction In Progress -- 1.1B 1.2B 1.7B 1.3B
Construction In Progress Total 1.7B 1.1B 1.2B 1.7B 1.3B
Intangible Assets 1.2B 884.0M 520.0M 442.0M 341.0M
Long Term Deferred Expenses 275.0M 336.0M 371.0M 309.0M 198.0M
Total Non Current Assets 14.8B 12.5B 11.4B 9.1B 6.7B
Total Assets 50.1B 43.8B 42.4B 39.3B 34.7B
Short Term Borrowings -- -- 1.3B -- --
Accounts Payable 2.0B 1.3B 1.5B 1.8B 1.3B
Advance Receipts -- -- -- -- --
Contract Liabilities 160.0M 198.0M 187.0M 220.0M 358.0M
Total Current Liabilities 3.6B 2.6B 3.6B 3.4B 3.8B
Long Term Borrowings -- -- -- -- --
Total Non Current Liabilities 412.0M 198.0M 319.0M 293.0M 171.0M
Total Liabilities 4.0B 2.8B 4.0B 3.7B 3.9B
Paid In Capital 6.4B 6.4B 6.4B 6.4B 5.3B
Capital Reserve 3.2B 3.1B 3.0B 3.4B 3.1B
Surplus Reserve 3.3B 3.3B 3.3B 3.1B 2.7B
Retained Earnings 33.9B 28.8B 25.5B 22.9B 20.8B
Minority Equity 570.0M 567.0M 589.0M 569.0M 283.0M
Equity Attributable 45.5B 40.5B 37.8B 35.0B 30.5B
Total Equity 46.1B 41.0B 38.4B 35.6B 30.8B
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
Cash From Sales 27.1B 24.1B 18.6B 25.0B 24.2B
Tax Refunds Received -- 65.6M 260.0M 167.0M 713,600
Total Operating Cash Inflow 28.5B 25.5B 19.6B 25.7B 24.5B
Cash Paid For Goods 1.4B 1.2B 1.1B 1.0B 1.1B
Cash Paid To Employees 6.2B 5.8B 6.2B 7.1B 5.6B
Taxes Paid 2.3B 1.6B 1.9B 1.8B 3.0B
Total Operating Cash Outflow 21.0B 17.8B 18.3B 21.5B 21.1B
Operating Cash Flow 7.4B 7.6B 1.3B 4.2B 3.4B
Total Investing Cash Inflow 680.0M 2.7B 9.8B 14.3B 30.0B
Total Investing Cash Outflow 2.6B 1.5B 9.4B 14.9B 28.2B
Investing Cash Flow -1.9B 1.2B 390.0M -546.0M 1.8B
Cash From Borrowings 800.0M 21.1M 1.3B -- --
Dividends And Interest Paid 1.3B 1.0B 1.0B 1.1B 1.0B
Debt Repayments 800.0M 1.3B -- -- --
Total Financing Cash Inflow 800.0M 21.1M 1.8B 342.0M 1.3B
Total Financing Cash Outflow 2.4B 3.2B 2.1B 1.3B 1.0B
Financing Cash Flow -1.6B -3.1B -319.0M -998.0M 291.0M
Net Change In Cash 4.0B 5.7B 1.4B 2.7B 5.4B
Ending Cash Balance 24.2B 20.3B 14.5B 13.1B 10.5B
Capex 2.0B 1.5B 2.0B 1.7B 554.0M
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...